Viewing Study NCT03610516


Ignite Creation Date: 2025-12-26 @ 11:48 AM
Ignite Modification Date: 2026-02-25 @ 7:22 PM
Study NCT ID: NCT03610516
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2018-06-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Nephritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None anti-CD40 View
None CFZ533 View
None moderately active lupus nephritis View